| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/03/2009 | US20090298046 Assays for Histone Deacetylase 1/2 Selective Inhibitors |
| 12/03/2009 | US20090298042 Three-dimensional skin model |
| 12/03/2009 | US20090297836 Strip electrode with conductive nano tube printing |
| 12/03/2009 | US20090297657 O-acetylhomoserinesulfhydorelace gene and use thereof |
| 12/03/2009 | US20090297647 Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells |
| 12/03/2009 | US20090297615 Nanoparticles, methods of making same and cell labeling using same |
| 12/03/2009 | US20090297573 Identifying and Modulating Molecular Pathways that Mediate Nervous System Plasticity |
| 12/03/2009 | US20090297563 Diagnosis And Treatment of Immune-Related Diseases |
| 12/03/2009 | US20090297557 Human parvovirus: bocavirus |
| 12/03/2009 | US20090297554 Multi Plasmid System For The Production Of Influenza Virus |
| 12/03/2009 | US20090297547 Pharmaceutical composition containing the nmb0938 protein |
| 12/03/2009 | US20090297537 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 12/03/2009 | US20090297536 Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer |
| 12/03/2009 | US20090297528 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 12/03/2009 | US20090297525 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer |
| 12/03/2009 | US20090297523 Erm family binding agents and their use in diagnosis and treatment of proliferative conditions |
| 12/03/2009 | US20090297518 Immunopotentiative composition |
| 12/03/2009 | US20090297514 Humanization of antibodies |
| 12/03/2009 | US20090297507 ADAM10 in Cancer Diagnosis, Detection and Treatment |
| 12/03/2009 | US20090297506 Classification of cancer |
| 12/03/2009 | US20090297501 Structural Isomers of sc(Fv)2 |
| 12/03/2009 | US20090297500 NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTION WITH RhoA |
| 12/03/2009 | US20090297494 Diagnostic and treatment of a mental disorder |
| 12/03/2009 | US20090297493 nanoporous particle with a retained target |
| 12/03/2009 | US20090297483 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 12/03/2009 | US20090297475 Cysteine dioxygenase polymorphisms |
| 12/03/2009 | US20090297474 Method for Detecting or Monitoring Sepsis by Analysing Cytokine mRNA Expression Levels |
| 12/03/2009 | US20090297456 Swallowtail motifs for imparting water solubility to porphyrinic compounds |
| 12/03/2009 | US20090297438 Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA) |
| 12/03/2009 | US20090297436 Antibodies to il-6 and use thereof |
| 12/03/2009 | US20090297403 Method for producing a bioreactor or lab-on-a-chip system and bioreactors or lab-on-a-chip systems produced therewith |
| 12/03/2009 | US20090294288 High-sensitivity proteolysis assay |
| 12/03/2009 | DE102008044911B3 Verfahren und Mittel zur Aktivierung von Gedächtnis-B-Lymphozyten The method and means of activation of memory B lymphocytes |
| 12/03/2009 | DE102008025992A1 Titerplatte, Leseeinrichtung hierfür und Verfahren zur Detektion eines Analyten, sowie deren Verwendung Titer plate, this reading device and method for detecting an analyte, and their use |
| 12/03/2009 | DE102008025965A1 Verfahren zur Isolierung von Zellen und Krankheitserregern aus Körperflüssigkeiten A process for the isolation of cells from body fluids and infectious agents |
| 12/03/2009 | DE102008025656A1 Verfahren zur quantitativen Analyse von Nikleinsäuren, Marker dafür und deren Verwendung A method for quantitative analysis of Nikleinsäuren, markers and their use for |
| 12/03/2009 | DE102008025328A1 Detecting HIV in a blood sample comprises providing and optionally concentrating the sample, extracting viral nucleic acids, adding the extract to PCR master mix and performing amplification and detecting the amplified viral nucleic acids |
| 12/03/2009 | DE102005003457B4 Verfahren und Teilesatz zur mikrobiologischen Bestimmung von Vitamen Method and set of parts for microbiological determination of Vitamen |
| 12/03/2009 | CA2763790A1 Compositions and methods for spatial separation and screening of cells |
| 12/03/2009 | CA2726571A1 Method for detecting respiratory viral agents in a test sample |
| 12/03/2009 | CA2726569A1 Methods and reagents for predicting clinical outcome and customizing chemotherapy in lung cancer patients |
| 12/03/2009 | CA2725983A1 Linezolid resistance mutations in gram-positive bacteria |
| 12/03/2009 | CA2725978A1 Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| 12/03/2009 | CA2725977A1 Enzymatic analytical membrane, test device and method |
| 12/03/2009 | CA2725882A1 Minichromosome maintenance complex interacting protein involved in cancer |
| 12/03/2009 | CA2725674A1 Novel selection marker gene and use thereof |
| 12/03/2009 | CA2725599A1 Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling |
| 12/03/2009 | CA2724638A1 Hybridization compositions and methods |
| 12/03/2009 | CA2721631A1 Methods and compositions for improved fertilization and embryonic survival |
| 12/03/2009 | CA2721503A1 Polymorphisms associated with age-related macular degeneration and methods for evaluating patient risk |
| 12/03/2009 | CA2720460A1 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 12/03/2009 | CA2720247A1 Single molecule loading methods and compositions |
| 12/02/2009 | EP2128620A1 System and apparatus for use in detecting microorganisms |
| 12/02/2009 | EP2128614A1 Microfluidic device containing lyophilized reagent therein and analyzing method using the same |
| 12/02/2009 | EP2128611A1 Method of evaluating foam-holding properties of fermented malt drink and marker for evaluating foam-holding properties |
| 12/02/2009 | EP2128275A2 Method and product for "in vitro" genotyping with applications in anti-ageing medicine |
| 12/02/2009 | EP2128274A1 Method for determination of presence of crossing with garden-species rose plant in wild-species rose plant |
| 12/02/2009 | EP2128273A1 Primer set for gene amplification, gene amplification reagent containing the same and use thereof |
| 12/02/2009 | EP2128272A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 12/02/2009 | EP2128271A1 Method for discriminating between nucleotide sequences of nucleic acids |
| 12/02/2009 | EP2128270A1 Osteoarthritis biomarkers and uses thereof |
| 12/02/2009 | EP2128269A1 Light emission modifiers and their uses in nucleic acid detection, amplification and analysis |
| 12/02/2009 | EP2128268A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 12/02/2009 | EP2128267A2 Methods of evaluating phosphatase inhibitors |
| 12/02/2009 | EP2128266A1 Method for detection of compound interacting with molecule located on cell membrane |
| 12/02/2009 | EP2128259A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 12/02/2009 | EP2128257A2 Mutation of the parkin gene, compositions, methods and uses |
| 12/02/2009 | EP2128246A1 Methods and composition for the production of orthoganal tRNA-Aminoacyl-tRNA synthetase pairs |
| 12/02/2009 | EP2126765A1 Nucleic acid sequencing system and method |
| 12/02/2009 | EP2126141A2 Screening, diagnosing, treating and prognosis of pathophysiologic states by rna regulation |
| 12/02/2009 | EP2126139A2 Molecular classifier for prognosis in multiple myeloma |
| 12/02/2009 | EP2126138A1 Dna chip for detection of staphylococcus aureus |
| 12/02/2009 | EP2126136A2 Diagnosis of prostate cancer |
| 12/02/2009 | EP2126135A2 Methods and kits for predicting prognosis of multiple sclerosis |
| 12/02/2009 | EP2126132A2 Methods for rapid foresnsic dna analysis |
| 12/02/2009 | EP2126131A2 Genemap of the human genes associated with schizophrenia |
| 12/02/2009 | EP2126129A2 Death associated protein kinase 1 (dapk1) and uses thereof for the treatment of chronic lymphocytic leukemia |
| 12/02/2009 | EP2126128A2 Gene expression profiling for identification, monitoring, and treatment of lupus erythematosus |
| 12/02/2009 | EP2126127A2 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 12/02/2009 | EP2126126A2 Gene polymorphisms in vegf and vegf receptor 2 as markers for cancer therapy |
| 12/02/2009 | EP2126125A2 Methods for diagnosis of maculopathies |
| 12/02/2009 | EP2126124A2 Marker sequences for labour |
| 12/02/2009 | EP2126123A1 Somatotransgenic bioimaging |
| 12/02/2009 | EP2126122A1 Method and test kit for determining the amounts of target sequences and nucleotide variations therein |
| 12/02/2009 | EP2126121A2 A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene |
| 12/02/2009 | EP2126120A1 Assay for gene expression |
| 12/02/2009 | EP2126119A1 Apparatus and method for nucleic acid amplification |
| 12/02/2009 | EP2126118A2 Method and kit for detection of mbcr/abl gene fusion and c-kit (cd117) |
| 12/02/2009 | EP2126117A2 Gene polymorphisms predictive for dual tki therapy |
| 12/02/2009 | EP2126116A2 Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers |
| 12/02/2009 | EP2126115A2 Diagnosis and prognosis of various types of cancers |
| 12/02/2009 | EP2126113A1 Diagnostic marker and platform for drug design in myocardial infarction and heart failure |
| 12/02/2009 | EP2126112A2 Gene polymorphisms as predictors of tumor progression and their use in cancer therapy |
| 12/02/2009 | EP2126111A1 Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule |
| 12/02/2009 | EP2126110A1 Measurement of the activity of a kynurenine-converting enzyme and/or of a kynurenic acid, anthranilic acid and/or 3-hydoxykynurenine-producing enzyme |
| 12/02/2009 | EP2126109A2 Biomarkers of sirtuin activity and methods of use thereof |
| 12/02/2009 | EP2126108A1 Detection system apparatus |
| 12/02/2009 | EP2126107A1 Ruthenium purple biosensor |
| 12/02/2009 | EP2126086A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 12/02/2009 | EP2126078A2 Composition and methods for modulating cell proliferation and cell death |